Su1906 MICROBIOTA-DEPENDENT EARLY LIFE PROGRAMMING OF GASTROINTESTINAL MOTILITY
Read More →
Maggio 2024
Risultati per: Microbiota e steatosi epatica: quali evidenze?
Questo è quello che abbiamo trovato per te
Sa1926 WASHED MICROBIOTA TRANSPLANTATION FOR REFRACTORY INTESTINAL INFECTIONS: FINDINGS FROM A NATIONAL MUTI-CENTER, REAL-WORLD STUDY
Read More →
Maggio 2024
Sa1927 ANTIBIOTIC TREATMENT PROMOTES THE INTESTINAL COLONISATION OF VANCOMYCIN-RESISTANT ENTEROCOCCUS BY KILLING MEMBERS OF THE GUT MICROBIOTA AND DECREASING NUTRIENT COMPETITION
Read More →
Maggio 2024
Sa1925 ASSESSING ANTIBIOTICS PALATABILITY AND METABOLIC IMPACT FOR ROBUST GUT MICROBIOTA STUDIES IN MICE
Read More →
Maggio 2024
Sa1885 THE LONGITUDINAL ANALYSIS OF FECAL MICROBIOTA IN RESPONCE TO USTEKINUMAB TREATMENT IN PATIENTS WITH CROHN'S DISEASE
Read More →
Maggio 2024
Su1638 THE DUODENAL MUCOSA-ASSOCIATED MICROBIOTA OF PATIENTS WITH A DISORDER OF GUT-BRAIN INTERACTION CAN BE DIFFERENTIATED BY ROME IV CRITERIA
Read More →
Maggio 2024
Sa1875 EVALUATING THE PRESENCE OF MUCOSAL TOLERANCE TO EACH MEMBER OF THE RESIDENT MICROBIOTA IN WILD-TYPE AND IL-10 KO 129 STRAIN MICE COLONIZED WITH THE ALTERED SCHAEDLER FLORA (ASF): IMPACT ON ABSOLUTE ABUNDANCE AND COLITIS
Read More →
Maggio 2024
Sa1873 EARLY LIFE FOOD ADDITIVE CARBOXYMETHYL CELLULOSE EXPOSURE TRIGGERED DYSBIOSIS OF GUT MICROBIOTA AND DEFECTIVE INTESTINAL BARRIER IN THE OFFSPRING
Read More →
Maggio 2024
Sa1871 THE COMPOSITION AND FUNCTION OF THE GUT MICROBIOTA IN A TREATMENT NAIVE INCEPTION COHORT OF INFLAMMATORY BOWEL DISEASE (IBD) CAN ACCURATELY DIFFERENTIATE IBD PHENOTYPE.
Read More →
Maggio 2024
Sa1917 ASYMPTOMATIC C. DIFFICILE CARRIAGE IS NOT UNCOMMON FOLLOWING SUCCESSFUL FECAL MICROBIOTA TRANSPLANTATION FOR RECURRENT C. DIFFICILE INFECTION
Read More →
Maggio 2024
Sa1913 REAL-WORLD EFFICACY AND SAFETY OF FECAL MICROBIOTA, LIVE-JSLM (REBYOTA) AND FECAL MICROBIOTA SPORES, LIVE-BRPK (VOWST) TO PREVENT RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTIONS: A TWO-CENTER EXPERIENCE.
Read More →
Maggio 2024
Sa1911 CLINICAL AND ECONOMIC OUTCOMES OF MICROBIOME THERAPY FOR PREVENTING RECURRENCE IN RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) IN THE US: COMPARISON OF FECAL MICROBIOTA SPORES, LIVE-BRPK (FORMERLY SER-109) VS FECAL MICROBIOTA, LIVE-JSLM
Read More →
Maggio 2024
Sa1901 EFFICACY AND SAFETY OF FECAL MICROBIOTA, LIVE-JSLM IN PARTICIPANTS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION RECEIVING CONCOMITANT MEDICATIONS
Read More →
Maggio 2024
Sa1903 DEEP PRECISION METAGENOMICS REVEALS DYNAMIC CHANGES IN MICROBIAL, VIRAL, AND PLASMID INTERACTION NETWORKS FOLLOWING INTESTINAL MICROBIOTA TRANSPLANTATION
Read More →
Maggio 2024
Su1768 A RANDOMIZED TRIAL OF ANTIMICROBIALS VERSUS PLACEBO IN ADDITION TO FECAL MICROBIOTA TRANSPLANT FOR THE INDUCTION OF REMISSION IN ACTIVE ULCERATIVE COLITIS
Read More →
Maggio 2024
Su1781 EFFICACY OF DIFFERENT MODALITIES OF FAECAL MICROBIOTA TRANSPLANTATION TO INDUCE CLINICAL REMISSION IN PATIENTS WITH ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
Read More →
Maggio 2024
